Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI118860

Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma.

P De Vos, A M Lefebvre, S G Miller, M Guerre-Millo, K Wong, R Saladin, L G Hamann, B Staels, M R Briggs, and J Auwerx

INSERM U325 and Départemente d'Atherosclerose, Institut Pasteur, Lille, France.

Find articles by De Vos, P. in: PubMed | Google Scholar

INSERM U325 and Départemente d'Atherosclerose, Institut Pasteur, Lille, France.

Find articles by Lefebvre, A. in: PubMed | Google Scholar

INSERM U325 and Départemente d'Atherosclerose, Institut Pasteur, Lille, France.

Find articles by Miller, S. in: PubMed | Google Scholar

INSERM U325 and Départemente d'Atherosclerose, Institut Pasteur, Lille, France.

Find articles by Guerre-Millo, M. in: PubMed | Google Scholar

INSERM U325 and Départemente d'Atherosclerose, Institut Pasteur, Lille, France.

Find articles by Wong, K. in: PubMed | Google Scholar

INSERM U325 and Départemente d'Atherosclerose, Institut Pasteur, Lille, France.

Find articles by Saladin, R. in: PubMed | Google Scholar

INSERM U325 and Départemente d'Atherosclerose, Institut Pasteur, Lille, France.

Find articles by Hamann, L. in: PubMed | Google Scholar

INSERM U325 and Départemente d'Atherosclerose, Institut Pasteur, Lille, France.

Find articles by Staels, B. in: PubMed | Google Scholar

INSERM U325 and Départemente d'Atherosclerose, Institut Pasteur, Lille, France.

Find articles by Briggs, M. in: PubMed | Google Scholar

INSERM U325 and Départemente d'Atherosclerose, Institut Pasteur, Lille, France.

Find articles by Auwerx, J. in: PubMed | Google Scholar

Published August 15, 1996 - More info

Published in Volume 98, Issue 4 on August 15, 1996
J Clin Invest. 1996;98(4):1004–1009. https://doi.org/10.1172/JCI118860.
© 1996 The American Society for Clinical Investigation
Published August 15, 1996 - Version history
View PDF
Abstract

The ob gene product, leptin, is a signaling factor regulating body weight and energy balance. ob gene expression in rodents is increased in obesity and is regulated by feeding patterns and hormones, such as insulin and glucocorticoids. In humans with gross obesity, ob mRNA levels are higher, but other modulators of human ob expression are unknown. In view of the importance of peroxisome proliferator-activated receptor gamma (PPARgamma) in adipocyte differentiation, we analyzed whether ob gene expression is subject to regulation by factors activating PPARs. Treatment of rats with the PPARalpha activator fenofibrate did not change adipose tissue and body weight and had no significant effect on ob mRNA levels. However, administration of the thiazolidinedione BRL49653, a PPARgamma ligand, increased food intake and adipose tissue weight while reducing ob mRNA levels in rats in a dose-dependent manner. The inhibitory action of the thiazolidinedione BRL49653 on ob mRNA levels was also observed in vitro. Thiazolidinediones reduced the expression of the human ob promoter in primary adipocytes, however, in undifferentiated 3T3-L1 preadipocytes lacking endogenous PPARgamma, cotransfection of PPARgamma was required to observe the decrease. In conclusion, these data suggest that PPARgamma activators reduce ob mRNA levels through an effect of PPARgamma on the ob promoter.

Version history
  • Version 1 (August 15, 1996): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts